TPU researchers register first Russian software for planning neutron therapy
Software for planning gamma-neutron therapy of malignant tumors developed by scientists of the Technological Reference Center for Ionizing Radiation in Radiology, Radiation Therapy and Nuclear Medicine of TPU and the Oncology Research Institute of Tomsk National Research Medical Center has been registered as intellectual property. The application allows medical physicists to more accurately calculate dose burden values when planning gamma neutron therapy of malignant tumors at the U-120 cyclotron, to optimize the distribution of absorbed dose in tissues and organs, and allows radiotherapists to assess potential risks and side effects for the patient. The development was supported by the Priority 2030 program of the Ministry of Education and Science.
